C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways. Journal of Applied Oral Science, [S. l.], v. 31, p. e20220404, 2023. DOI: 10.1590/1678-7757-2022-0404. Disponível em: https://www.revistas.usp.br/jaos/article/view/207724.. Acesso em: 2 may. 2024.